[1]
Rock, K.L.; Latz, E.; Ontiveros, F.; Kono, H. The sterile inflammatory response. Annu. Rev. Immunol., 2010, 28, 321-342.
[2]
Serhan, C.N.; Chiang, N.; Dalli, J.; Levy, B.D. Lipid mediators in the resolution of inflammation. Cold Spring Harb. Perspect. Biol., 2015, 7, a016311.
[3]
Gabay, C.; Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med., 1999, 340, 448-454.
[4]
Brodsky, I.E.; Medzhitov, R. Targeting of immune signalling networks by bacterial pathogens. Nat. Cell Biol., 2009, 11, 521-526.
[5]
Krysko, D.V.; Agostinis, P.; Krysko, O.; Garg, A.D.; Bachert, C.; Lambrecht, B.N.; Vandenabeele, P. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol., 2011, 32, 157-164.
[6]
Pasare, C.; Medzhitov, R. Toll-like receptors: Linking innate and adaptive immunity. Microbes Infect., 2004, 6, 1382-1387.
[7]
Gauldie, J.; Richards, C.; Harnish, D.; Lansdorp, P.; Baumann, H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA, 1987, 84, 7251-7255.
[8]
Ceciliani, F.; Giordano, A.; Spagnolo, V. The systemic reaction during inflammation: The acute-phase proteins. Protein Pept. Lett., 2002, 9, 211-223.
[9]
Kann, R.K.C.; Seddon, J.M.; Henning, J.; Meers, J. Acute phase proteins in healthy and sick cats. Res. Vet. Sci., 2012, 93, 649-654.
[10]
Murata, H.; Shimada, N.; Yoshioka, M. Current research on acute phase proteins in veterinary diagnosis: An overview. Vet. J., 2004, 168, 28-40.
[11]
Petersen, H.H.; Nielsen, J.P.; Heegaard, P.M.H. Application of acute phase protein measurements in veterinary clinical chemistry. Vet. Res., 2004, 35, 163-187.
[12]
Heegaard, P.M.H.; Miller, I.; Sorensen, N.S.; Soerensen, K.E.; Skovgaard, K. Pig α1-acid glycoprotein: Characterization and first description in any species as a negative acute phase protein. PLoS One, 2013, 8, e68110.
[13]
Gambacorti-Passerini, C.; le Coutre, P.; Zucchetti, M.; D’Incalci, M. Binding of imatinib by alpha(1)-acid glycoprotein. Blood, 2002, 100, 367-368.
[14]
Ceciliani, F.; Pocacqua, V. The acute phase protein alpha1-acid glycoprotein: A model for altered glycosylation during diseases. Curr. Protein Pept. Sci., 2007, 8, 91-108.
[15]
Chiu, K.M.; Mortensen, R.F.; Osmand, A.P.; Gewurz, H. Interactions of alpha1-acid glycoprotein with the immune system. I. purification and effects upon lymphocyte responsiveness. Immunology, 1977, 32, 997-1005.
[16]
Ceciliani, F.; Pocacqua, V.; Miranda-Ribera, A.; Bronzo, V.; Lecchi, C.; Sartorelli, P. Alpha(1)-acid glycoprotein modulates apoptosis in bovine monocytes. Vet. Immunol. Immunopathol., 2007, 116, 145-152.
[17]
Åkerstrom, B.; Flower, D.R.; Salier, J.P. Lipocalins: Unity in diversity. Biochim. Biophys. Acta, 2000, 1482, 1-8.
[18]
Lakshmi, B.; Mishra, M.; Srinivasan, N.; Archunan, G. Structure-based phylogenetic analysis of the lipocalin superfamily. PLoS One, 2015, 10, e0135507.
[19]
Lögdberg, L.; Wester, L. Immunocalins: A lipocalin subfamily that modulates immune and inflammatory responses. Biochim. Biophys. Acta, 2000, 1482, 284-297.
[20]
Nakano, M.; Kakehi, K.; Tsai, M.H.; Lee, Y.C. Detailed structural features of glycan chains derived from alpha1-acid glycoproteins of several different animals: The presence of hypersialylated, O-acetylated sialic acids but not disialy1 residues. Glycobiology, 2004, 14, 431-441.
[21]
Schmid, K.; Kaufmann, H.; Isemura, S.; Bauer, F.; Emura, J.; Motoyama, T.; Ishiguro, M.; Nanno, S. Structure of 1 -acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins. Biochemistry, 1973, 12, 2711-2724.
[22]
Schmid, K.; Bürgi, W.; Collins, J.H.; Nanno, S. The disulfide bonds of alpha1-acid glycoprotein. Biochemistry, 1974, 13, 2694-2697.
[23]
Colombo, S.; Buclin, T.; Décosterd, L.A.; Telenti, A.; Furrer, H.; Lee, B.L.; Biollaz, J.; Eap, C.B. Orosomucoid (Alpha1-Acid Glycoprotein) plasma concentration and genetic variants: Effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation. Clin. Pharmacol. Ther., 2006, 80, 307-318.
[24]
Dente, L.; Pizza, M.G.; Metspalu, A.; Cortese, R. Structure and expression of the genes coding for human alpha1-acid glyco-protein. EMBO J., 1987, 6, 2289-2296.
[25]
Eap, C.B.; Baumann, P. The genetic polymorphism of human alpha1-acid glycoprotein. Prog. Clin. Biol. Res., 1989, 300, 111-125.
[26]
Yuasa, I.; Weidinger, S.; Umetsu, K.; Suenaga, K.; Ishimoto, G.; Eap, B.C.; Duche, J.C.; Baumann, P. Orosomucoid system: 17 additional orosomucoid variants and proposal for a new nomenclature. Vox Sang., 1993, 64, 47-55.
[27]
Chang, C.J.; Lai, M.A.; Chen, D.S.; Lee, S.C. Structure and expression of mouse alpha1 -acid glycoprotein gene-3 (AGP-3). DNA Cell Biol., 1992, 11, 315-320.
[28]
Lee, S.C.; Chang, C.J.; Lee, Y.M.; Lei, H.Y.; Lai, M.Y.; Chen, D.S. Molecular cloning of CDNAs corresponding to two genes of alpha1-acid glycoprotein and characterization of two alleles of AGP-1 in the mouse. DNA (Mary Ann Liebert, Inc.), 1989, 8, 245-251.
[29]
Prowse, K.R.; Baumann, H. Molecular characterization and acute phase expression of the multiple mus caroli alpha1-Acid Glycoprotein (AGP) genes: Differences in glucocorticoid stimulation and regulatory elements between the rat and mouse AGP genes. J. Biol. Chem., 1990, 265, 10201-10209.
[30]
Elsik, C.G.; Tellam, R.L.; Worley, K.C.; Gibbs, R.A.; Muzny, D.M.; Weinstock, G.M.; Adelson, D.L.; Eichler, E.E.; Elnitski, L.; Guigo, R.; Hamernik, D.L.; Kappes, S.M.; Lewin, H.A.; Lynn, D.J.; Nicholas, F.W.; Reymond, A.; Rijnkels, M.; Skow, L.C.; Zdobnov, E.M.; Schook, L.; Womack, J.; Alioto, T.; Antonarakis, S.E.; Astashyn, A.; Chapple, C.E.; Chen, H-C.; Chrast, J.; Camara, F.; Ermolaeva, O.; Henrichsen, C.N.; Hlavina, W.; Kapustin, Y.; Kiryutin, B.; Kitts, P.; Kokocinski, F.; Landrum, M.; Maglott, D.; Pruitt, K.; Sapojnikov, V.; Searle, S.M.; Solovyev, V.; Souvorov, A.; Ucla, C.; Wyss, C.; Anzola, J.M.; Gerlach, D.; Elhaik, E.; Graur, D.; Reese, J.T.; Edgar, R.C.; McEwan, J.C.; Payne, G.M.; Raison, J.M.; Junier, T.; Kriventseva, E.V.; Eyras, E.; Plass, M.; Donthu, R.; Larkin, D.M.; Reecy, J.; Yang, M.Q.; Chen, L.; Cheng, Z.; Chitko-McKown, C.G.; Liu, G.E.; Matukumalli, L.K.; Song, J.; Zhu, B.; Bradley, D.G.; Brinkman, F.S.L.; Lau, L.P.L.; Whiteside, M.D.; Walker, A.; Wheeler, T.T.; Casey, T.; German, J.B.; Lemay, D.G.; Maqbool, N.J.; Molenaar, A.J.; Seo, S.; Stothard, P.; Baldwin, C.L.; Baxter, R.; Brinkmeyer-Langford, C.L.; Brown, W.C.; Childers, C.P.; Connelley, T.; Ellis, S.A.; Fritz, K.; Glass, E.J.; Herzig, C.T.A.; Iivanainen, A.; Lahmers, K.K.; Bennett, A.K.; Dickens, C.M.; Gilbert, J.G.R.; Hagen, D.E.; Salih, H.; Aerts, J.; Caetano, A.R.; Dalrymple, B.; Garcia, J.F.; Gill, C.A.; Hiendleder, S.G.; Memili, E.; Spurlock, D.; Williams, J.L.; Alexander, L.; Brownstein, M.J.; Guan, L.; Holt, R.A.; Jones, S.J.M.; Marra, M.A.; Moore, R.; Moore, S.S.; Roberts, A.; Taniguchi, M.; Waterman, R.C.; Chacko, J.; Chandrabose, M.M.; Cree, A.; Dao, M.D.; Dinh, H.H.; Gabisi, R.A.; Hines, S.; Hume, J.; Jhangiani, S.N.; Joshi, V.; Kovar, C.L.; Lewis, L.R.; Liu, Y-s.; Lopez, J.; Morgan, M.B.; Nguyen, N.B.; Okwuonu, G.O.; Ruiz, S.J.; Santibanez, J.; Wright, R.A.; Buhay, C.; Ding, Y.; Dugan-Rocha, S.; Herdandez, J.; Holder, M.; Sabo, A.; Egan, A.; Goodell, J.; Wilczek-Boney, K.; Fowler, G.R.; Hitchens, M.E.; Lozado, R.J.; Moen, C.; Steffen, D.; Warren, J.T.; Zhang, J.; Chiu, R.; Schein, J.E.; Durbin, K.J.; Havlak, P.; Jiang, H.; Liu, Y.; Qin, X.; Ren, Y.; Shen, Y.; Song, H.; Bell, S.N.; Davis, C.; Johnson, A.J.; Lee, S.; Nazareth, L.V.; Patel, B.M.; Pu, L-L.; Vattathil, S.; Williams, R.L.; Curry, S.; Hamilton, C.; Sodergren, E.; Wheeler, D.A.; Barris, W.; Bennett, G.L.; Eggen, A.; Green, R.D.; Harhay, G.P.; Hobbs, M.; Jann, O.; Keele, J.W.; Kent, M.P.; Lien, S.; McKay, S.D.; McWilliam, S.; Ratnakumar, A.; Schnabel, R.D.; Smith, T.; Snelling, W.M.; Sonstegard, T.S.; Stone, R.T.; Sugimoto, Y.; Takasuga, A.; Taylor, J.F.; Van Tassell, C.P.; MacNeil, M.D.; Abatepaulo, A.R.R.; Abbey, C.A.; Ahola, V.; Almeida, I.G.; Amadio, A.F.; Anatriello, E.; Bahadue, S.M.; Biase, F.H.; Boldt, C.R.; Carroll, J.A.; Carvalho, W.A.; Cervelatti, E.P.; Chacko, E.; Chapin, J.E.; Cheng, Y.; Choi, J.; Colley, A.J.; de Campos, T.A.; De Donato, M.; Santos, I.K.F.M.; de Oliveira, C.J.F.; Deobald, H.; Devinoy, E.; Donohue, K.E.; Dovc, P.; Eberlein, A.; Fitzsimmons, C.J.; Franzin, A.M.; Garcia, G.R.; Genini, S.; Gladney, C.J.; Grant, J.R.; Greaser, M.L.; Green, J.A.; Hadsell, D.L.; Hakimov, H.A.; Halgren, R.; Harrow, J.L.; Hart, E.A.; Hastings, N.; Hernandez, M.; Hu, Z-L.; Ingham, A.; Iso-Touru, T.; Jamis, C.; Jensen, K.; Kapetis, D.; Kerr, T.; Khalil, S.S.; Khatib, H.; Kolbehdari, D.; Kumar, C.G.; Kumar, D.; Leach, R.; Lee, J.C-M.; Li, C.; Logan, K.M.; Malinverni, R.; Marques, E.; Martin, W.F.; Martins, N.F.; Maruyama, S.R.; Mazza, R.; McLean, K.L.; Medrano, J.F.; Moreno, B.T.; More, D.D.; Muntean, C.T.; Nandakumar, H.P.; Nogueira, M.F.G.; Olsaker, I.; Pant, S.D.; Panzitta, F.; Pastor, R.C.P.; Poli, M.A.; Poslusny, N.; Rachagani, S.; Ranganathan, S.; Razpet, A.; Riggs, P.K.; Rincon, G.; Rodriguez-Osorio, N.; Rodriguez-Zas, S.L.; Romero, N.E.; Rosenwald, A.; Sando, L.; Schmutz, S.M.; Shen, L.; Sherman, L.; Southey, B.R.; Lutzow, Y.S.; Sweedler, J.V.; Tammen, I.; Telugu, B.P.V.L.; Urbanski, J.M.; Utsunomiya, Y.T.; Verschoor, C.P.; Waardenberg, A.J.; Wang, Z.; Ward, R.; Weikard, R.; Welsh, T.H.; White, S.N.; Wilming, L.G.; Wunderlich, K.R.; Yang, J.; Zhao, F-Q. The genome sequence of taurine cattle: A window to ruminant biology and evolution. Science, 2009, 324, 522-528.
[31]
Ricca, G.A.; Hamilton, R.W.; McLean, J.W.; Conn, A.; Kalinyak, J.E.; Taylor, J.M. Rat alpha1-acid glycoprotein MRNA. cloning of double-stranded CDNA and kinetics of induction of MRNA levels following acute inflammation. J. Biol. Chem., 1981, 256, 10362-10368.
[32]
Ceciliani, F.; Pocacqua, V.; Provasi, E.; Comunian, C.; Bertolini, A.; Bronzo, V.; Moroni, P.; Sartorelli, P. Identification of the bovine alpha1-acid glycoprotein in colostrum and milk. Vet. Res., 2005, 36, 735-746.
[33]
Pocacqua, V.; Provasi, E.; Paltrinieri, S.; Gelain, E.; Comunian, C.; Ceciliani, F. Glycan moiety modifications of feline alpha1-acid glycoprotein in retrovirus (FIV, FeLV) affected cats. Vet. Immunol. Immunopathol., 2005, 107, 17-26.
[34]
Stone, R.T.; Maurer, R.A. Cloning and developmental regulation of alpha1 acid glycoprotein in swine. Dev. Genet., 1987, 8, 295-304.
[35]
Ray, B.K.; Ray, A. Molecular cloning and nucleotide sequence of complementary DNA encoding rabbit alpha1-acid glycoprotein. Biochem. Biophys. Res. Commun., 1991, 178, 507-513.
[36]
Schönfeld, D.L.; Ravelli, R.B.G.; Mueller, U.; Skerra, A. The 1.8-Å crystal structure of α1-acid glycoprotein (orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin. J. Mol. Biol., 2008, 384, 393-405.
[37]
Nishi, K.; Ono, T.; Nakamura, T.; Fukunaga, N.; Izumi, M.; Watanabe, H.; Suenaga, A.; Maruyama, T.; Yamagata, Y.; Curry, S.; Otagiri, M. Structural insights into differences in drug-binding selectivity between two forms of human alpha1-acid glycoprotein genetic variants, the A and F1*S forms. J. Biol. Chem., 2011, 286, 14427-14434.
[38]
Matsumoto, K.; Sukimoto, K.; Nishi, K.; Maruyama, T.; Suenaga, A.; Otagiri, M. Characterization of ligand binding sites on the alpha1-acid glycoprotein in humans, bovines and dogs. Drug Metab. Pharmacokinet., 2002, 17, 300-306.
[39]
Nishi, K.; Maruyama, T.; Halsall, H.B.; Handa, T.; Otagiri, M. Binding of alpha1-acid glycoprotein to membrane results in a unique structural change and ligand release. Biochemistry, 2004, 43, 10513-10519.
[40]
Nishi, K.; Sakai, N.; Komine, Y.; Maruyama, T.; Halsall, H.B.; Otagiri, M. Structural and drug-binding properties of alpha(1)-acid glycoprotein in reverse micelles. Biochim. Biophys. Acta, 2002, 1601, 185-191.
[41]
Blom, N.; Gammeltoft, S.; Brunak, S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol., 1999, 294, 1351-1362.
[42]
Blom, N.; Sicheritz-Pontén, T.; Gupta, R.; Gammeltoft, S.; Brunak, S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics, 2004, 4, 1633-1649.
[43]
Bhide, G.P.; Colley, K.J. Sialylation of N-glycans: Mechanism, cellular compartmentalization and function. Histochem. Cell Biol., 2017, 147, 149-174.
[44]
Budai, L.; Pollreisz, F.; Ozohanics, O.; Ludányi, K.; Drahos, L.; Vékey, K. Letter: Analysis of complex oligosaccharides using graphitized carbon liquid chromatography/mass spectrometry. Eur. J. Mass Spectrom. , 2008, 14, 419-422.
[45]
Ongay, S.; Neususs, C. Isoform differentiation of intact AGP from human serum by capillary electrophoresis-mass spectrometry. Anal. Bioanal. Chem., 2010, 398, 845-855.
[46]
Treuheit, M.J.; Costello, C.E.; Halsall, H.B. Analysis of the five glycosylation sites of human alpha1-acid glycoprotein. Biochem. J., 1992, 283(Pt 1), 105-112.
[47]
Poland, D.C.W.; García Vallejo, J-J.; Niessen, H.W.M.; Nijmeyer, R.; Calafat, J.; Hack, C.E.; Van het Hof, B.; Van Dijk, W. Activated human PMN synthesize and release a strongly fucosylated glycoform of alpha1-acid glycoprotein, which is transiently deposited in human myocardial infarction. J. Leukoc. Biol., 2005, 78, 453-461.
[48]
Rahman, M.M.D.; Miranda-Ribera, A.; Lecchi, C.; Bronzo, V.; Sartorelli, P.; Franciosi, F.; Ceciliani, F. Alpha(1)-acid glycoprotein is contained in bovine neutrophil granules and released after activation. Vet. Immunol. Immunopathol., 2008, 125, 71-81.
[49]
Lecchi, C.; Scarafoni, A.; Bronzo, V.; Martino, P.A.; Cavallini, A.; Sartorelli, P.; Ceciliani, F. Alpha1-acid glycoprotein modulates phagocytosis and killing of Escherichia coli by bovine polymorphonuclear leucocytes and monocytes. Vet. J., 2013, 196, 47-51.
[50]
Baumann, H.; Prowse, K.R.; Marinovic, S.; Won, K.A.; Jhreisa, G.P. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann. N. Y. Acad. Sci., 1989, 557, 280-296.
[51]
Baumann, H.; Gauldie, J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol. Biol. Med., 1990, 7, 147-159.
[52]
Alam, T.; Papaconstantinou, J. Interaction of acute-phase-inducible and liver-enriched nuclear factors with the promoter region of the mouse alpha1-acid glycoprotein gene-1. Biochemistry, 1992, 31, 1928-1936.
[53]
Wigmore, S.J.; Fearon, K.C.; Maingay, J.P.; Lai, P.B.; Ross, J. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am. J. Physiol., 1997, 273, E720-E726.
[54]
Ramsay, T.G.; Stoll, M.J.; Blomberg, L.A.; Caperna, T.J. Regulation of cytokine gene expression by orosomucoid in neonatal swine adipose tissue. J. Anim. Sci. Biotechnol., 2016, 7, 25.
[55]
Koj, A.; Guzdek, A.; Nakamura, T.; Kordula, T. Hepatocyte growth factor and retinoic acid exert opposite effects on synthesis of type 1 and type 2 acute phase proteins in rat hepatoma cells. Int. J. Biochem. Cell Biol., 1995, 27, 39-46.
[56]
Li, X.; Sumi, T.; Matsukawa, T.; Nakanishi, Y.; Ohba, Y. Thyroid hormone, all-trans retinoic acid, and 9-cis retinoic acid functioned as negative modulators of the effect of glucocorticoid on induction of alpha1-acid glycoprotein MRNA in RLN-10 cells. Biochem. Mol. Biol. Int., 1998, 45, 1-10.
[57]
Fournier, T.; Medjoubi-N, N.; Porquet, D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta, 2000, 1482, 157-171.
[58]
Weisman, S.; Goldsmith, B.; Winzler, R.; Lepper, M. Turnover of plasma orosomucoid in man. J. Lab. Clin. Med., 1961, 57, 7-15.
[59]
Brée, F.; Houin, G.; Barré, J.; Moretti, J.L.; Wirquin, V.; Tillement, J.P. Pharmacokinetics of intravenously administered 125i-labelled human alpha1-acid glycoprotein. Clin. Pharmacokinet., 1986, 11, 336-342.
[60]
Poland, D.C.W.; Kulik, W.; Van Dijk, W.; Hallemeesch, M.M.; Jakobs, C.; De Meer, K. Distinct glycoforms of human α1-acid glycoprotein have comparable synthesis rates: A [13c]valine-labelling study in healthy humans. Glycoconj. J., 2004, 20, 99-105.
[61]
Regoeczi, E.; Debanne, M.T.; Hatton, M.C.; Koj, A. Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism. Biochim. Biophys. Acta, 1978, 541, 372-384.
[62]
McCurdy, T.R.; Bhakta, V.; Eltringham-Smith, L.J.; Gataiance, S.; Fox-Robichaud, A.E.; Sheffield, W.P. In vivo clearance of alpha-1 acid glycoprotein is influenced by the extent of its N-linked glycosylation and by its interaction with the vessel wall. J. Biomed. Biotechnol., 2012, 2012, 1-11.
[63]
Kuribayashi, T.; Seita, T.; Momotani, E.; Yamazaki, S.; Hagimori, K.; Yamamoto, S. Elimination half-lives of acute phase proteins in rats and beagle dogs during acute inflammation. Inflammation, 2015, 38, 1401-1405.
[64]
Komori, H.; Nishi, K.; Uehara, N.; Watanabe, H.; Shuto, T.; Suenaga, A.; Maruyama, T.; Otagiri, M. Characterization of hepatic cellular uptake of alpha1-acid glycoprotein (AGP), part 2: involvement of hemoglobin beta-chain on plasma membranes in the uptake of human agp by liver parenchymal cells. J. Pharm. Sci., 2012, 101, 1607-1615.
[65]
Nishi, K.; Komori, H.; Kikuchi, M.; Uehara, N.; Fukunaga, N.; Matsumoto, K.; Watanabe, H.; Nakajou, K.; Misumi, S.; Suenaga, A.; Maruyama, T.; Otagiri, M. Characterization of the hepatic cellular uptake of alpha1-acid glycoprotein (AGP), Part 1: A peptide moiety of human AGP is recognized by the hemoglobin beta-chain on mouse liver parenchymal cells. J. Pharm. Sci., 2012, 101, 1599-1606.
[66]
Gendler, S.J.; Dermer, G.B.; Silverman, L.M.; Tökés, Z.A. Synthesis of alpha1-antichymotrypsin and alpha1-acid glycoprotein by human breast epithelial cells. Cancer Res., 1982, 42, 4567-4573.
[67]
Fournier, T.; Bouach, N.; Delafosse, C.; Crestani, B.; Aubier, M. Inducible expression and regulation of the alpha1-acid glycoprotein gene by alveolar macrophages: Prostaglandin E2 and cyclic AMP act as new positive stimuli. J. Immunol., 1999, 163, 2883-2890.
[68]
Sörensson, J.; Matejka, G.L.; Ohlson, M.; Haraldsson, B. Human endothelial cells produce orosomucoid, an important component of the capillary barrier. Am. J. Physiol., 1999, 276, H530-H534.
[69]
Rice, A.; Grimshaw, J.; Trocha-Grimshaw, J.; McCarron, P.; Wisdom, G.B. Identification of alpha1-acid glycoprotein (orosomucoid) in human synovial fluid by capillary electrophoresis. J. Chromatogr. A, 1997, 772, 305-311.
[70]
Poland, D.C.W.; Kratz, E.; Vermeiden, J.P.W.; De Groot, S.M.; Bruyneel, B.; De Vries, T.; Van Dijk, W. High level of alpha1-acid glycoprotein in human seminal plasma is associated with high branching and expression of lewisa groups on its glycans: Supporting evidence for a prostatic origin. Prostate, 2002, 52, 34-42.
[71]
Shibata, Y.; Tamura, K.; Ishida, N. Cultured human monocytes, granulocytes and a monoblastoid cell line (THP-1) synthesize and secrete immunosuppressive acidic protein (a type of alpha1-acid glycoprotein). Microbiol. Immunol., 1984, 28, 99-111.
[72]
Nakamura, T.; Board, P.G.; Matsushita, K.; Tanaka, H.; Matsuyama, T.; Matsuda, T. Alpha1-acid glycoprotein expression in human leukocytes: Possible correlation between alpha1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis. Inflammation, 1993, 17, 33-45.
[73]
Ceciliani, F.; Rahman, M.M.; Lecchi, C.; Maccalli, M.; Pisoni, G.; Sartorelli, P. Systemic and in vitro expression of goat α1-acid glycoprotein during caprine arthritis-encephalitis virus infection. Vet. Immunol. Immunopathol., 2009, 131, 50-58.
[74]
Gahmberg, C.G.; Andersson, L.C. Leukocyte surface origin of human alpha1-acid glycoprotein (orosomucoid). J. Exp. Med., 1978, 148, 507-521.
[75]
Tsukahara, Y.; Lian, Z.; Zhang, X.; Whitney, C.; Kluger, Y.; Tuck, D.; Yamaga, S.; Nakayama, Y.; Weissman, S.M.; Newburger, P.E. Gene expression in human neutrophils during activation and priming by bacterial lipopolysaccharide. J. Cell. Biochem., 2003, 89, 848-861.
[76]
Theilgaard-Monch, K. Highly glycosylated 1-acid glycoprotein is synthesized in myelocytes, stored in secondary granules, and released by activated neutrophils. J. Leukoc. Biol., 2005, 78, 462-470.
[77]
Thomas, T.; Fletcher, S.; Yeoh, G.C.; Schreiber, G. The expression of alpha(1)-acid glycoprotein MRNA during rat development. high levels of expression in the decidua. J. Biol. Chem., 1989, 264, 5784-5790.
[78]
Thomas, T.; Southwell, B.R.; Schreiber, G.; Jaworowski, A. Plasma protein synthesis and secretion in the visceral yolk sac of the fetal rat: Gene expression, protein synthesis and secretion. Placenta, 1990, 11, 413-430.
[79]
Lecchi, C.; Avallone, G.; Giurovich, M.; Roccabianca, P.; Ceciliani, F. Extra hepatic expression of the acute phase protein alpha1-acid glycoprotein in normal bovine tissues. Vet. J., 2009, 180, 256-258.
[80]
Dilda, F.; Pisani, L.F.; Rahman, M.M.; Modina, S.; Tessaro, I.; Sartorelli, P.; Ceciliani, F.; Lecchi, C. Distribution of acute phase proteins in the bovine forestomachs and abomasum. Vet. J., 2012, 192, 101-105.
[81]
Paltrinieri, S.; Marchini, I.; Gelain, M.E. Flow cytometric detection of alpha-1-acid glycoprotein on feline circulating leucocytes. Aust. Vet. J., 2012, 90, 291-296.
[82]
Guiraudie, G.; Pageat, P.; Cain, A.H.; Madec, I.; Nagnan-Le Meillour, P. Functional characterization of olfactory binding proteins for appeasing compounds and molecular cloning in the vomeronasal organ of pre-pubertal pigs. Chem. Senses, 2003, 28, 609-619.
[83]
Rødgaard, T.; Stagsted, J.; Christoffersen, B.Ø.; Cirera, S.; Moesgaard, S.G.; Sturek, M.; Alloosh, M.; Heegaard, P.M.H. Orosomucoid expression profiles in liver, adipose tissues and serum of lean and obese domestic pigs, göttingen minipigs and ossabaw minipigs. Vet. Immunol. Immunopathol., 2013, 151, 325-330.
[84]
Atemezem, A.; Mbemba, E.; Vassy, R.; Slimani, H.; Saffar, L.; Gattegno, L. Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages. Biochem. J., 2001, 356, 121-128.
[85]
Sun, Y.; Yang, Y.; Qin, Z.; Cai, J.; Guo, X.; Tang, Y.; Wan, J.; Su, D-F.; Liu, X. The acute-phase protein orosomucoid regulates food intake and energy homeostasis via leptin receptor signaling pathway. Diabetes, 2016, 65, 1630-1641.
[86]
Huang, J.X.; Azad, M.A.K.; Yuriev, E.; Baker, M.A.; Nation, R.L.; Li, J.; Cooper, M.A.; Velkov, T. Molecular characterization of lipopolysaccharide binding to human α -1-acid glycoprotein. J. Lipids, 2012, 2012, 1-15.
[87]
Moore, D.F.; Rosenfeld, M.R.; Gribbon, P.M.; Winlove, C.P.; Tsai, C.M. Alpha-1-acid (AAG, orosomucoid) glycoprotein: Interaction with bacterial lipopolysaccharide and protection from sepsis. Inflammation, 1997, 21, 69-82.
[88]
McNamara, P.J.; Brouwer, K.R.; Gillespie, M.N. Autacoid binding to serum proteins. Interaction of Platelet Activating Factor (PAF) with human serum Alpha-1-Acid Glycoprotein (AAG). Biochem. Pharmacol., 1986, 35, 621-624.
[89]
Chachaj, W.; Bartecka, Z.; Małolepszy, J. Histamine binding proteins separated from human sera by the chromatographic method. Arch. Immunol. Ther. Exp. (Warsz.), 1980, 28, 947-951.
[90]
Boncela, J.; Smolarczyk, K.; Wyroba, E.; Cierniewski, C.S. Binding of PAI-1 to endothelial cells stimulated by thymosin beta4 and modulation of their fibrinolytic potential. J. Biol. Chem., 2006, 281, 1066-1072.
[91]
Zsila, F.; Mády, G. Biliverdin is the endogenous ligand of human serum α1-acid glycoprotein. Biochem. Biophys. Res. Commun., 2008, 372, 503-507.
[92]
Overhaus, M. Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 290, G695-G703.
[93]
Schnitzer, J.E.; Pinney, E. Quantitation of specific binding of orosomucoid to cultured microvascular endothelium: Role in capillary permeability. Am. J. Physiol., 1992, 263, H48-H55.
[94]
Curry, F.E.; Rutledge, J.C.; Lenz, J.F. Modulation of microvessel wall charge by plasma glycoprotein orosomucoid. Am. J. Physiol., 1989, 257, H1354-H1359.
[95]
Muchitsch, E.M.; Teschner, W.; Linnau, Y.; Pichler, L. In vivo effect of alpha1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skin. Arch. Int. Pharmacodyn. Ther., 1996, 331, 313-321.
[96]
Kuebler, J.F.; Toth, B.; Yokoyama, Y.; Bland, K.I.; Rue, L.W.; Chaudry, I.H. Alpha1-acid-glycoprotein protects against trauma-hemorrhagic shock. J. Surg. Res., 2004, 119, 21-28.
[97]
Zhang, S.; Mark, K.S. Alpha1-acid glycoprotein induced effects in rat brain microvessel endothelial cells. Microvasc. Res., 2012, 84, 161-168.
[98]
Sörensson, J.; Ohlson, M.; Björnson, A.; Haraldsson, B. Orosomucoid has a CAMP-dependent effect on human endothelial cells and inhibits the action of histamine. Am. J. Physiol. Heart Circ. Physiol., 2000, 278, H1725-H1731.
[99]
Bogatcheva, N.V.; Zemskova, M.A.; Kovalenkov, Y.; Poirier, C.; Verin, A.D. Molecular mechanisms mediating protective effect of CAMP on Lipopolysaccharide (LPS)-induced Human Lung Microvascular Endothelial Cells (HLMVEC) hyperpermeability. J. Cell. Physiol., 2009, 221, 750-759.
[100]
Matsumoto, K.; Nishi, K.; Kikuchi, M.; Kadowaki, D.; Tokutomi, Y.; Tokutomi, N.; Nishi, K.; Suenaga, A.; Otagiri, M. Alpha1-acid glycoprotein suppresses rat acute inflammatory paw edema through the inhibition of neutrophils activation and prostaglandin E2 generation. Biol. Pharm. Bull., 2007, 30, 1226-1230.
[101]
Costello, M.J.; Gewurz, H.; Siegel, J.N. Inhibition of neutrophil activation by alpha1-acid glycoprotein. Clin. Exp. Immunol., 1984, 55, 465-472.
[102]
Lainé, E.; Couderc, R.; Roch-Arveiller, M.; Vasson, M.P.; Giroud, J.P.; Raichvarg, D. Modulation of human polymorphonuclear neutrophil functions by alpha1-acid glycoprotein. Inflammation, 1990, 14, 1-9.
[103]
Vasson, M.P.; Roch-Arveiller, M.; Couderc, R.; Baguet, J.C.; Raichvarg, D. Effects of alpha-1 acid glycoprotein on human polymorphonuclear neutrophils: Influence of glycan microheterogeneity. Clin. Chim. Acta, 1994, 224, 65-71.
[104]
Mestriner, F.L.C.; Spiller, F.; Laure, H.J.; Souto, F.O.; Tavares-Murta, B.M.; Rosa, J.C.; Basile-Filho, A.; Ferreira, S.H.; Greene, L.J.; Cunha, F.Q. Acute-phase protein alpha-1-acid glycoprotein mediates neutrophil migration failure in sepsis by a nitric oxide-dependent mechanism. Proc. Natl. Acad. Sci. USA, 2007, 104, 19595-19600.
[105]
Spiller, F.; Carlos, D.; Souto, F.O.; de Freitas, A.; Soares, F.S.; Vieira, S.M.; Paula, F.J.A.; Alves-Filho, J.C.; Cunha, F.Q. Alpha1-acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice. Diabetes, 2012, 61, 1584-1591.
[106]
Mccurdy, T.R.; Patrick, A.L.; Eltringham-Smith, L.J.; Bhakta, V.; Sheffield, W.P.; Fox-Robichaud, A.E. Alpha-1 acid glycoprotein reduces hepatic leukocyte recruitment in murine models of either early endotoxemia or early sepsis. Microcirculation, 2014, 21, 74-83.
[107]
Lecchi, C.; Ceciliani, F.; Bernasconi, S.; Franciosi, F.; Bronzo, V.; Sartorelli, P. Bovine alpha-1 acid glycoprotein can reduce the chemotaxis of bovine monocytes and modulate CD18 expression. Vet. Res., 2008, 39, 50.
[108]
Gunnarsson, P.; Levander, L.; Pahlsson, P.; Grenegard, M. The acute-phase protein 1-acid glycoprotein (AGP) induces rises in cytosolic Ca2+ in neutrophil granulocytes via sialic acid binding immunoglobulin-like lectins (Siglecs). FASEB J., 2007, 21, 4059-4069.
[109]
Hampton, M.B.; Kettle, A.J.; Winterbourn, C.C. Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing. Blood, 1998, 92, 3007-3017.
[110]
Komori, H.; Watanabe, H.; Shuto, T.; Kodama, A.; Maeda, H.; Watanabe, K.; Kai, H.; Otagiri, M.; Maruyama, T. Alpha1-acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: Possible protection against hemolysis-induced oxidative stress. J. Biol. Chem., 2012, 287, 30688-30700.
[111]
Beckmann, S.; Long, T.; Scheld, C.; Geyer, R.; Caffrey, C.R.; Grevelding, C.G. Serum albumin and α-1 acid glycoprotein impede the killing of schistosoma mansoni by the tyrosine kinase inhibitor imatinib. Int. J. Parasitol. Drugs Drug Resist., 2014, 4, 287-295.
[112]
Liu, J.; Marey, M.A.; Kowsar, R.; Hambruch, N.; Shimizu, T.; Haneda, S.; Matsui, M.; Sasaki, M.; Hayakawa, H.; Pfarrer, C.; Miyamoto, A. An acute-phase protein as a regulator of sperm survival in the bovine oviduct: Alpha1-acid-glycoprotein impairs neutrophil phagocytosis of sperm in vitro. J. Reprod. Dev., 2014, 60, 342-348.
[113]
Miranda-Ribera, A.; Lecchi, C.; Bronzo, V.; Scaccabarozzi, L.; Sartorelli, P.; Franciosi, F.; Ceciliani, F. Down-regulatory effect of alpha1-acid glycoprotein on bovine neutrophil degranulation. Comp. Immunol. Microbiol. Infect. Dis., 2010, 33, 291-306.
[114]
Rinaldi, M.; Ceciliani, F.; Lecchi, C.; Moroni, P.; Bannerman, D.D. Differential effects of alpha1-acid glycoprotein on bovine neutrophil respiratory burst activity and IL-8 production. Vet. Immunol. Immunopathol., 2008, 126, 199-210.
[115]
Bories, P.N.; Feger, J.; Benbernou, N.; Rouzeau, J.D.; Agneray, J.; Durand, G. Prevalence of tri- and tetraantennary glycans of human alpha1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity. Inflammation, 1990, 14, 315-323.
[116]
Tilg, H.; Vannier, E.; Vachino, G.; Dinarello, C.A.; Mier, J.W. Antiinflammatory properties of hepatic acute phase proteins: Preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J. Exp. Med., 1993, 178, 1629-1636.
[117]
Elg, S.A.; Mayer, A.R.; Carson, L.F.; Twiggs, L.B.; Hill, R.B.; Ramakrishnan, S. Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovarian carcinoma. Cancer, 1997, 80, 1448-1456.
[118]
Aso, H.; Tamura, K.; Rose, M.T.; Tomioka, Y.; Mizugaki, M.; Ishida, N. Effect of alpha1-acidic glycoprotein in the ascitic fluid of cancer patients on human nk cells: Selective suppression of interferon-induced NK activation. Inflammation, 1999, 23, 117-129.
[119]
Su, S.J.; Yang, B.C.; Wang, Y.S.; Yeh, T.M. Alpha1-acid glycoprotein-induced tumor necrosis factor-alpha secretion of human monocytes is enhanced by serum binding proteins and depends on protein tyrosine kinase activation. Immunopharmacology, 1999, 41, 21-29.
[120]
Su, S.J.; Yeh, T.M. Effects of alpha1-acid glycoprotein on tissue factor expression and tumor necrosis factor secretion in human monocytes. Immunopharmacology, 1996, 34, 139-145.
[121]
Boutten, A.; Dehoux, M.; Deschenes, M.; Rouzeau, J.D.; Bories, P.N.; Durand, G. Alpha1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. Eur. J. Immunol., 1992, 22, 2687-2695.
[122]
Shiyan, S.D.; Bovin, N.V. Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha1-acid glycoprotein. Glycoconj. J., 1997, 14, 631-638.
[123]
Shemyakin, I.G.; Pukhalsky, A.L.; Stepanshina, V.N.; Shmarina, G.V.; Aleshkin, V.A.; Afanas’ev, S.S. Preventive and therapeutic effects of alpha-acid glycoprotein in mice infected with B. anthracis. Bull. Exp. Biol. Med., 2005, 140, 439-444.
[124]
Declerck, P.J.; De Mol, M.; Alessi, M.C.; Baudner, S.; Paques, E.P.; Preissner, K.T.; Muller-Berghaus, G.; Collen, D. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. identification as a multimeric form of S protein (vitronectin). J. Biol. Chem., 1988, 263, 15454-15461.
[125]
Berk, B.C.; Taubman, M.B.; Cragoe, E.J.; Fenton, J.W.; Griendling, K.K. Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and -independent pathways. J. Biol. Chem., 1990, 265, 17334-17340.
[126]
Rocanin-Arjo, A.; Cohen, W.; Carcaillon, L.; Frère, C.; Saut, N.; Letenneur, L.; Alhenc-Gelas, M.; Dupuy, A.M.; Bertrand, M.; Alessi, M.C.; Germain, M.; Wild, P.S.; Zeller, T.; Cambien, F.; Goodall, A.H.; Amouyel, P.; Scarabin, P.Y.; Trégouët, D.A.; Morange, P.E. A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential. Blood, 2014, 123, 777-785.
[127]
Costello, M.; Fiedel, B.A.; Gewurz, H. Inhibition of platelet aggregation by native and desialised alpha-1 acid glycoprotein. Nature, 1979, 281, 677-678.
[128]
Snyder, S.; Coodley, E.L. Inhibition of platelet aggregation by alpha1-acid glycoprotein. Arch. Intern. Med., 1976, 136, 778-781.
[129]
Gunnarsson, P.; Levander, L.; Påhlsson, P.; Grenegård, M. A1-Acid Glycoprotein (AGP)-induced platelet shape change involves the rho/rho kinase signalling pathway. Thromb. Haemost., 2009, 102, 694-703.
[130]
Van Molle, W.; Libert, C.; Fiers, W.; Brouckaert, P. Alpha1-acid glycoprotein and alpha1-antitrypsin inhibit TNF-induced but not anti-fas-induced apoptosis of hepatocytes in mice. J. Immunol., 1997, 159, 3555-3564.
[131]
Van Molle, W.; Denecker, G.; Rodriguez, I.; Brouckaert, P.; Vandenabeele, P.; Libert, C. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J. Immunol., 1999, 163, 5235-5241.
[132]
Lage, R.; Moscoso, I.; Fernández-Trasancos, Á.; Cebro, M.; Couselo, M.; Fandiño-Vaquero, R.; Bravo, S.B.; Sierra, J.; González-Juanatey, J.R.; Eiras, S. Differential behaviour of epicardial adipose tissue-secretomes with high and low orosomucoid levels from patients with cardiovascular disease in H9C2 cells. Mol. Cell. Endocrinol., 2015, 416, 77-87.
[133]
Daemen, M.A.; Heemskerk, V.H.; van’t Veer, C.; Denecker, G.; Wolfs, T.G.; Vandenabeele, P.; Buurman, W.A. Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation, 2000, 102, 1420-1426.
[134]
de Vries, B.; Walter, S.J.; Wolfs, T.G.A.M.; Hochepied, T.; Räbinä, J.; Heeringa, P.; Parkkinen, J.; Libert, C.; Buurman, W.A. Exogenous alpha-1-acid glycoprotein protects against renal ischemia-reperfusion injury by inhibition of inflammation and apoptosis. Transplantation, 2004, 78, 1116-1124.
[135]
Irmak, S.; Oliveira-Ferrer, L.; Singer, B.B.; Ergün, S.; Tilki, D. Pro-angiogenic properties of Orosomucoid (ORM). Exp. Cell Res., 2009, 315, 3201-3209.
[136]
Ligresti, G.; Aplin, A.C.; Dunn, B.E.; Morishita, A.; Nicosia, R.F. The acute phase reactant orosomucoid-1 is a bimodal regulator of angiogenesis with time- and context-dependent inhibitory and stimulatory properties. PLoS One, 2012, 7, e41387.
[137]
Miranda-Ribera, A.; Passaniti, A.; Ceciliani, F.; Goldblum, S.E. A1-acid glycoprotein disrupts capillary-like tube formation of human lung microvascular endothelia. Exp. Lung Res., 2014, 40, 507-519.
[138]
Singh, V.K.; Hugh Fudenberg, H. Lymphocyte stimulation in vitro by orosomucoid glycoprotein. Immunol. Lett., 1986, 14, 9-13.
[139]
Bennett, M.; Schmid, K. Immunosuppression by human plasma alpha1-acid glycoprotein: importance of the carbohydrate moiety. Proc. Natl. Acad. Sci. USA, 1980, 77, 6109-6113.
[140]
Cheresh, D.A.; Haynes, D.H.; Distasio, J.A. Interaction of an acute phase reactant, alpha1-acid glycoprotein (Orosomucoid), with the lymphoid cell surface: A model for non-specific immune suppression. Immunology, 1984, 51, 541-548.
[141]
Pos, O.; Oostendorp, R.A.J.; Van Der Stelt, M.E.; Scheper, R.J.; Van Dijk, W. Con a-nonreactive human alpha1-acid glycoprotein (AGP) is more effective in modulation of lymphocyte proliferation than Con a-reactive AGP serum variants. Inflammation, 1990, 14, 133-141.
[142]
Havenaar, E.C.; Hoff, R.C.; Van Den Eijnden, D.H.; Van Dijk, W. Sialyl Lewis(x) epitopes do not occur on acute phase proteins in mice: Relationship to the absence of alpha3-fucosyltransferase in the liver. Glycoconj. J., 1998, 15, 389-395.
[143]
De Graaf, T.W. Inflammation-induced expression of sialyl lewis X-containing glycan structures on alpha1-acid glycoprotein (Orosomucoid) in human sera. J. Exp. Med., 1993, 177, 657-666.
[144]
Levander, L.; Gunnarsson, P.; Grenegård, M.; Rydén, I.; Påhlsson, P. Effects of alpha1-acid glycoprotein fucosylation on its Ca2+ mobilizing capacity in neutrophils. Scand. J. Immunol., 2009, 69, 412-420.
[145]
Williams, J.P.; Weiser, M.R.; Pechet, T.T.; Kobzik, L.; Moore, F.D.; Hechtman, H.B. Alpha1-acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat. Am. J. Physiol., 1997, 273, G1031-G1035.
[146]
Ceciliani, F.; Grossi, C.; Giordano, A.; Pocacqua, V.; Paltrinieri, S. Decreased sialylation of the acute phase protein alpha1-acid glycoprotein in Feline Infectious Peritonitis (FIP). Vet. Immunol. Immunopathol., 2004, 99, 229-236.
[147]
Rossi, G.; Capitani, L.; Ceciliani, F.; Restelli, L.; Paltrinieri, S. Hyposialylated alpha1-acid glycoprotein inhibits phagocytosis of feline neutrophils. Res. Vet. Sci., 2013, 95, 465-471.
[148]
Jo, M.; Kim, J-H.; Song, G.J.; Seo, M.; Hwang, E.M.; Suk, K. Astrocytic orosomucoid-2 modulates microglial activation and neuroinflammation. J. Neurosci., 2017, 37, 2878-2894.
[149]
Brinkman-Van der Linden, E.C.; Mollicone, R.; Oriol, R.; Larson, G.; Van den Eijnden, D.H.; Van Dijk, W. A Missense mutation in the FUT6 gene results in total absence of alpha3-fucosylation of human alpha1-acid glycoprotein. J. Biol. Chem., 1996, 271, 14492-14495.
[150]
Van Dijk, W.; Havenaar, E.C.; Brinkman-Van Der Linden, E.C.M. Alpha1-acid glycoprotein (Orosomucoid): Pathophysiological changes in glycosylation in relation to its function. Glycoconj. J., 1995, 12, 227-233.
[151]
Marques, A.T.; Nordio, L.; Lecchi, C.; Grilli, G.; Giudice, C.; Ceciliani, F. Widespread extrahepatic expression of acute-phase proteins in healthy chicken (Gallus gallus) tissues. Vet. Immunol. Immunopathol., 2017, 190, 10-17.
[152]
Kalmovarin, N.; Friedrichs, W.E.; O’Brien, H.V.; Linehan, L.A.; Bowman, B.H.; Yang, F. Extrahepatic expression of plasma protein genes during inflammation. Inflammation, 1991, 15, 369-379.
[153]
Martìnez Cordero, E.; Gonzàlez, M.M.; Aguilar, L.D.; Orozco, E.H.; Hernàndez Pando, R. Alpha-1-Acid Glycoprotein, Its Local Production and Immunopathological Participation in Experimental Pulmonary Tuberculosis. Tuberculosis , 2008, 88, 203-211.
[154]
Ríos-Barrera, V.A.; Campos-Peña, V.; Aguilar-León, D.; Lascurain, L.R.; Meraz-Ríos, M.A.; Moreno, J.; Figueroa-Granados, V.; Hernández-Pando, R. Macrophage and T lymphocyte apoptosis during experimental pulmonary tuberculosis: Their relationship to mycobacterial virulence. Eur. J. Immunol., 2006, 36, 345-353.
[155]
Kowsar, R.; Hambruch, N.; Marey, M.A.; Liu, J.; Shimizu, T.; Pfarrer, C.; Miyamoto, A. Evidence for a novel, local acute-phase response in the bovine oviduct: Progesterone and lipopolysaccharide up-regulate alpha1-acid-glycoprotein expression in epithelial cells in vitro. Mol. Reprod. Dev., 2014, 81, 861-870.
[156]
Hotamisligil, G.S. Inflammation, metaflammation and immunometabolic disorders. Nature, 2017, 542, 177-185.
[157]
Alfadda, A.A.; Fatma, S.; Chishti, M.A.; Al-Naami, M.Y.; Elawad, R.; Mendoza, C.D.O.; Jo, H.; Lee, Y.S. Orosomucoid serum concentrations and fat depot-specific MRNA and protein expression in humans. Mol. Cells, 2012, 33, 35-41.
[158]
Lee, Y.S.; Choi, J.W.; Hwang, I.; Lee, J.W.; Lee, J.H.; Kim, A.Y.; Huh, J.Y.; Koh, Y.J.; Koh, G.Y.; Son, H.J.; Masuzaki, H.; Hotta, K.; Alfadda, A.A.; Kim, J.B. Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. J. Biol. Chem., 2010, 285, 22174-22185.
[159]
Asterholm, I.W.; McDonald, J.; Blanchard, P-G.; Sinha, M.; Xiao, Q.; Mistry, J.; Rutkowski, J.M.; Deshaies, Y.; Brekken, R.A.; Scherer, P.E. Lack of “immunological fitness” during fasting in metabolically challenged animals. J. Lipid Res., 2012, 53, 1254-1267.
[160]
Ferrari, M.; Cuenca-García, M.; Valtueña, J.; Moreno, L.A.; Censi, L.; González-Gross, M.; Androutsos, O.; Gilbert, C.C.; Huybrechts, I.; Dallongeville, J.; Sjöström, M.; Molnar, D.; De Henauw, S.; Gómez-Martínez, S.; de Moraes, A.C.F.; Kafatos, A.; Widhalm, K.; Leclercq, C. Inflammation profile in overweight/obese adolescents in Europe: An analysis in relation to iron status. Eur. J. Clin. Nutr., 2015, 69, 247-255.
[161]
Agra, R.M.; Varela-Román, A.; González-Ferreiro, R.; Viñuela, J.E.; Castro-Pais, A.; Fernández-Trasancos, Á.; Díaz-Rodríguez, E.; Álvarez, E.; Carreira, M.C.; Casanueva, F.F.; González-Juanatey, J.R.; Eiras, S. Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure. Int. J. Cardiol., 2017, 228, 488-494.
[162]
Rahman, M.M.; Lecchi, C.; Sauerwein, H.; Mielenz, M.; Häußler, S.; Restelli, L.; Giudice, C.; Ceciliani, F. Expression of α1-acid glycoprotein and lipopolysaccharide binding protein in visceral and subcutaneous adipose tissue of dairy cattle. Vet. J., 2015, 203, 223-227.
[163]
Restelli, L.; Codrea, M.C.; Savoini, G.; Ceciliani, F.; Bendixen, E. LC-MS/MS analysis of visceral and subcutaneous adipose tissue proteomes in young goats with focus on innate immunity and inflammation related proteins. J. Proteomics, 2014, 108, 295-305.
[164]
Ramsay, T.G.; Blomberg, L.; Caperna, T.J. α 1-acid glycoprotein inhibits lipogenesis in neonatal swine adipose tissue. Animal, 2016, 10, 812-820.
[165]
Zeyda, M.; Stulnig, T.M. Adipose tissue macrophages. Immunol. Lett., 2007, 112, 61-67.
[166]
Akter, S.H.; Haussler, S.; Germeroth, D.; Von Soosten, D.; Danicke, S.; Sudekum, K.H.; Sauerwein, H. Immunohistochemical characterization of phagocytic immune cell infiltration into different adipose tissue depots of dairy cows during early lactation. J. Dairy Sci., 2012, 95, 3032-3044.
[167]
Häussler, S.; Germeroth, D.; Laubenthal, L.; Ruda, L.F.; Rehage, J.; Dänicke, S.; Sauerwein, H. Short communication: Immunohistochemical localization of the immune cell marker cd68 in bovine adipose tissue: Impact of tissue alterations and excessive fat accumulation in dairy cows. Vet. Immunol. Immunopathol., 2017, 183, 45-48.
[168]
Friedman, M.J. Control of malaria virulence by delta1-acid glycoprotein (Orosomucoid), an acute-phase (Inflammatory) reactant. Proc. Natl. Acad. Sci. USA, 1983, 80, 5421-5424.
[169]
Bharara, R.; Singh, S.; Pattnaik, P.; Chitnis, C.E.; Sharma, A. Structural analogs of sialic acid interfere with the binding of erythrocyte binding antigen-175 to glycophorin a, an interaction crucial for erythrocyte invasion by Plasmodium falciparum. Mol. Biochem. Parasitol., 2004, 138, 12-129.
[170]
Maeda, H.; Morinaga, T.; Mori, I.; Nishi, K. Further characterization of the effects of alpha-1-acid glycoprotein on the passage of human erythrocytes through micropores. Cell Struct. Funct., 1984, 9, 279-290.
[171]
Matsumoto, K.; Nishi, K.; Tokutomi, Y.; Irie, T.; Suenaga, A.; Otagiri, M. Effects of alpha1-acid glycoprotein on erythrocyte deformability and membrane stabilization. Biol. Pharm. Bull., 2003, 26, 123-126.
[172]
Percário, S.; Moreira, D.; Gomes, B.; Ferreira, M.; Gonçalves, A.; Laurindo, P.; Vilhena, T.; Dolabela, M.; Green, M. Oxidative stress in malaria. Int. J. Mol. Sci., 2012, 13, 16346-16372.
[173]
Gupta, S.K.; Oppenheim, J.D.; Glick, J.; Schulman, S.; Vanderberg, J.P. Lack of inhibitory effects of alpha1-acid glycoprotein (Orosomucoid) on Plasmodium falciparum invasion of human erythrocytes. Am. J. Trop. Med. Hyg., 1985, 34, 441-446.
[174]
Athamna, A.; Kramer, M.R.; Kahane, I. Adherence of mycoplasma pneumoniae to human alveolar macrophages. FEMS Immunol. Med. Microbiol., 1996, 15, 135-141.
[175]
Hochepied, T.; Van Molle, W.; Berger, F.G.; Baumann, H.; Libert, C. Involvement of the acute phase protein α1-acid glycoprotein in nonspecific resistance to a lethal gram-negative infection. J. Biol. Chem., 2000, 275, 14903-14909.
[176]
Seddiki, N.; Rabehi, L.; Benjouad, A.; Saffar, L.; Ferriere, F.; Gluckman, J.C.; Gattegno, L. Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes. Glycobiology, 1997, 7, 1229-1236.
[177]
Watanabe, K.; Ishima, Y.; Akaike, T.; Sawa, T.; Kuroda, T.; Ogawa, W.; Watanabe, H.; Suenaga, A.; Kai, T.; Otagiri, M.; Maruyama, T. S-Nitrosated α-1-acid glycoprotein kills drug-resistant bacteria and aids survival in sepsis. FASEB J., 2013, 27, 391-398.
[178]
O’Reilly, E.L.; Eckersall, P.D. Acute phase proteins: A review of their function, behaviour and measurement in chickens. Worlds Poult. Sci. J., 2014, 70, 27-44.
[179]
Adler, K.L.; Peng, P.H.; Peng, R.K.; Klasing, K.C. The kinetics of hemopexin and a1-acid glycoprotein levels induced by injection of inflammatory agents in chickens. Avian Dis., 2001, 45, 289.
[180]
Chen, J.; Tellez, G.; Richards, J.D.; Escobar, J. Identification of potential biomarkers for gut barrier failure in broiler chickens. Front. Vet. Sci., 2015, 2, 14.
[181]
Nakamura, O.; Nozawa, Y.; Saito, E.; Ikeda, D.; Tsutsui, S. An alpha-1-acid glycoprotein-like protein as a major component of the ovarian cavity fluid of viviparous fish, Neoditrema ransonnetii (Perciformes, Embiotocidae). Comp. Biochem. Physiol. A Mol. Integr. Physiol., 2009, 153, 222-229.
[182]
Nakamura, O.; Watabe, Y.; Matsumoto, N.; Takasugi, O.; Watanabe, A.; Tsutsui, S. Localization and possible function of NrF-AGP, an alpha-1-acid glycoprotein-like protein in viviparous fish Neoditrema ransonnetii (Perciformes, Embiotocidae). Fish Physiol. Biochem., 2014, 40, 1907-1915.
[183]
Saito, E.; Nakamura, O.; Yamada, H.; Tsutsui, S.; Watanabe, T. Suppression of lymphocyte proliferation by ovarian cavity fluid from the viviparous fish Neoditrema ransonnetii (Perciformes; Embiotocidae). Fish Shellfish Immunol., 2009, 27, 549-555.
[184]
Yokozawa, N.; Nakamura, O.; Saito, E.; Tsutsui, S. Ovarian cavity fluid of the viviparous surfperch Neoditrema ransonnetii suppresses the spontaneous cytotoxic activity of head-kidney leucocytes against xenogeneic targets. J. Fish Biol., 2015, 86, 139-147.
[185]
Machnes, Z.; Avtalion, R.; Shirak, A.; Trombka, D.; Wides, R.; Fellous, M.; Don, J. Male-Specific Protein (MSP): A new gene linked to sexual behavior and aggressiveness of tilapia males. Horm. Behav., 2008, 54, 442-449.
[186]
de Castro, E.; Sigrist, C.J.A.; Gattiker, A.; Bulliard, V.; Langendijk-Genevaux, P.S.; Gasteiger, E.; Bairoch, A.; Hulo, N. ScanProsite: Detection of PROSITE signature matches and prorule-associated functional and structural residues in proteins. Nucleic Acids Res., 2006, 34, W362-W365.
[187]
Schauer, R.; Kamerling, J.P. Glycoproteins II. Montreuil, J.; Vliegenhart, J.F.G; Schachter, H., Ed.; Elsevier: Amsterdam, 1997.